ScholarIQanswers from OpenAlex & ORCID
Vijay Patil
ResearcherPublications, citations & collaboration network
Vijay Patil is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Vijay Patil have?
ScholarIQindexed works
Vijay Patil has 379 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Vijay Patil have?
ScholarIQcitation count
Vijay Patil has 4,409 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Vijay Patil?
ScholarIQh-index
Vijay Patil has an h-index of 31 in OpenAlex.
What is the i10-index of Vijay Patil?
ScholarIQi10-index
Vijay Patil has an i10-index of 89 in OpenAlex.
What is the ORCID of Vijay Patil?
ScholarIQorcid
The ORCID for Vijay Patil is on the source record.
What is the OpenAlex record for Vijay Patil?
ScholarIQopenalex
The OpenAlex for Vijay Patil is on the source record.
What are the most-cited papers on Vijay Patil?
ScholarIQmost cited works
Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in <i>EGFR</i>-Mutated Lung Cancer
Vanita Noronha, Vijay Patil, Amit Joshi, Nandini Menon, Anuradha Chougule, Abhishek Mahajan, Amit Janu, Nilendu Purandare, Rajiv Kumar, Sucheta More, Supriya Goud, Nandkumar Kadam, Nilesh Daware, Atanu Bhattacharjee, Srushti Shah, Akanksha Yadav, Vaishakhi Trivedi, Vichitra Behel, Amit Dutt, Shripad Banavali, Kumar Prabhash
Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial
Vanita Noronha, Amit Joshi, Vijay Patil, Jaiprakash Agarwal, Sarbani Ghosh Laskar, Ashwini Budrukkar, Vedang Murthy, Tejpal Gupta, Anil D′Cruz, Shripad Banavali, Prathamesh Pai, Pankaj Chaturvedi, Devendra Chaukar, Nikhil Pande, Arun Chandrasekharan, Vikas Talreja, Dilip Harindran Vallathol, Vijayalakshmi Mathrudev, Aparna Manjrekar, Kamesh Maske, Arati Sanjay Bhelekar, Kavita Nawale, Sadhana Kannan, Vikram Gota, Atanu Bhattacharjee, Shubhada Kane, Shashikant Juvekar, Kumar Prabhash
Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized Study
Vijay Patil, Vanita Noronha, Nandini Menon, Rahul Rai, Atanu Bhattacharjee, Ajay Singh, Kavita Nawale, Shweta Jogdhankar, Rupali Tambe, Sachin Dhumal, Riddhi Sawant, Mitali Alone, Devanshi Karla, Zoya Peelay, Shruti Pathak, Arun Balaji, Suman Kumar, Nilendu Purandare, Archi Agarwal, Ameya Puranik, Abhishek Mahajan, Amit Janu, Gunjesh Kumar Singh, Neha Mittal, Subhash Yadav, Shripad Banavali, Kumar Prabhash
Neoadjuvant chemotherapy followed by surgery in very locally advanced technically unresectable oral cavity cancers
Vijay Patil, Kumar Prabhash, Vanita Noronha, Amit Joshi, Vamshi Muddu, Sachin Dhumal, S. Arya, S Juvekar, P. Chaturvedi, Devendra Chaukar, Prathamesh Pai, Shubhada Kane, Aswari Patil, J.P. Agarwal, S. Ghosh-Lashkar, Anil D′Cruz
A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer
Vijay Patil, Vanita Noronha, Amit Joshi, Jaiprakash Agarwal, Sarbani Ghosh Laskar, Ashwini Budrukkar, Vedang Murthy, Tejpal Gupta, Manoj B. Mahimkar, Shashikant Juvekar, Supreeta Arya, Abhishek Mahajan, Archi Agarwal, Nilendu Purandare, Venkatesh Rangarajan, Arun Balaji, Sameer Chaudhari, Shripad Banavali, Sadhana Kannan, Atanu Bhattacharjee, Anil D′Cruz, Pankaj Chaturvedi, Prathamesh Pai, Devendra Chaukar, Gouri Pantvaidya, Deepa Nair, Sudhir Nair, Anuja Deshmukh, Shivakumar Thiagarajan, Vijayalakshmi Mathrudev, Aparna Manjrekar, Sachin Dhumal, Kamesh Maske, Arti Bhelekar, Kavita Nawale, Arun Chandrasekharan, Nikhil Pande, Alok Goel, Vikas Talreja, Vijai Simha, Sujay Srinivas, Rohit Swami, Dilip Harindran Vallathol, Hollis Dsouza, Sameer Shrirangwar, Siddharth Turkar, George Abraham, Aditi Harsh Thanky, Usha Patel, Manish Pandey, Kumar Prabhash